Rhumbline Advisers increased its position in LHC Group, Inc. (NASDAQ:LHCG) by 16.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 38,021 shares of the health services provider’s stock after acquiring an additional 5,371 shares during the quarter. Rhumbline Advisers’ holdings in LHC Group were worth $2,329,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio grew its holdings in shares of LHC Group by 4,288.5% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 56,129 shares of the health services provider’s stock worth $3,981,000 after acquiring an additional 54,850 shares during the period. BNP Paribas Arbitrage SA grew its holdings in shares of LHC Group by 54.0% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 8,662 shares of the health services provider’s stock worth $614,000 after acquiring an additional 3,037 shares during the period. Vident Investment Advisory LLC acquired a new stake in shares of LHC Group in the 3rd quarter worth approximately $2,448,000. Schwab Charles Investment Management Inc. grew its holdings in shares of LHC Group by 8.7% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 113,771 shares of the health services provider’s stock worth $8,069,000 after acquiring an additional 9,078 shares during the period. Finally, Cadence Capital Management LLC grew its holdings in shares of LHC Group by 20.7% in the 3rd quarter. Cadence Capital Management LLC now owns 26,654 shares of the health services provider’s stock worth $1,890,000 after acquiring an additional 4,568 shares during the period. Institutional investors and hedge funds own 89.76% of the company’s stock.
In other LHC Group news, COO Donald Dwayne Stelly sold 14,216 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $64.00, for a total transaction of $909,824.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 14.80% of the company’s stock.
A number of equities research analysts recently weighed in on LHCG shares. ValuEngine cut LHC Group from a “buy” rating to a “hold” rating in a report on Friday, December 1st. BidaskClub cut LHC Group from a “sell” rating to a “strong sell” rating in a report on Wednesday, March 7th. Zacks Investment Research upgraded LHC Group from a “hold” rating to a “strong-buy” rating and set a $70.00 target price on the stock in a report on Tuesday, March 6th. Stephens set a $74.00 target price on LHC Group and gave the company a “buy” rating in a report on Friday, March 2nd. Finally, Robert W. Baird set a $71.00 target price on LHC Group and gave the company a “hold” rating in a report on Tuesday, November 28th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. LHC Group currently has an average rating of “Buy” and an average price target of $76.70.
Shares of LHC Group, Inc. (NASDAQ LHCG) opened at $63.07 on Tuesday. The company has a market capitalization of $1,162.76, a price-to-earnings ratio of 26.83, a price-to-earnings-growth ratio of 1.49 and a beta of 0.68. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.28. LHC Group, Inc. has a fifty-two week low of $49.56 and a fifty-two week high of $76.14.
LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, February 28th. The health services provider reported $0.62 EPS for the quarter, meeting analysts’ consensus estimates of $0.62. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The firm had revenue of $292.40 million for the quarter, compared to analysts’ expectations of $280.82 million. During the same quarter in the prior year, the firm earned $0.58 EPS. LHC Group’s quarterly revenue was up 24.2% on a year-over-year basis. equities research analysts forecast that LHC Group, Inc. will post 3.03 earnings per share for the current year.
WARNING: This piece was reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.thestockobserver.com/2018/03/20/rhumbline-advisers-grows-position-in-lhc-group-inc-lhcg.html.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.